Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy

Petros Grivas, Tarek A. Bismar, Aijai S. Alva, Huei Chung Huang, Yang Liu, Roland Seiler, Nimira Alimohamed, Liang Cheng, M. Eric Hyndman, Bashar Dabbas, Peter C. Black, Elai Davicioni, Jonathan L. Wright, Moshe C. Ornstein, Omar Y. Mian, Hristos Z. Kaimakliotis, Ewan A. Gibb, Yair Lotan